TheraRadar
← Back
Data updated: Sep 20, 2026

SHILPA MEDICARE LTD

Pharma
Pharmaceuticals

SHILPA MEDICARE LTD is a pharmaceutical company with 2 FDA-approved products.

-
Since
2
Drugs
-
Trials
0
New Drugs (2yr)

SHILPA MEDICARE LTD's Key Drugs

SHILPA MEDICARE LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

SHILPA MEDICARE LTD's Recent FDA Approvals

New NDA/BLA approvals for SHILPA MEDICARE LTD over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

SHILPA MEDICARE LTD's Therapeutic Areas

Disease areas where SHILPA MEDICARE LTD has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

SHILPA MEDICARE LTD Pipeline Snapshot

Active clinical trials for SHILPA MEDICARE LTD across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Active trial monitoring
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling